Who are Small Molecules's investors?

Small Molecules's investors include 8VC, Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, RTW Investments L.P., The Column Group, Thuja Capital, Two Sigma Ventures.

How much funding has Small Molecules raised?

Small Molecules has disclosed $13.1M raised across 3 rounds.

Where is Small Molecules headquartered?

Small Molecules is headquartered in Santa Monica, US.

Small Molecules

Santa Monica, US · Founded 2021 · Delaware corporation · 10 known investors

Founders & leadership

Michael EinzigerExecutive

Edna CoryellExecutive

Katherine PowerNamed on SEC filing

Jessica GoldinNamed on SEC filing

Board

Ann Marie SimpsonBoard director

Investors · 10

8VCreportedAustin · $100K – $50M

Droia VenturesreportedLeuven · $540K

Frazier Life SciencesreportedPalo Alto

Novartis Venture FundreportedBasel · $5M – $25M

RTW Investments L.P.reportedNew York

The Column GroupreportedSan Francisco · $30M

Thuja CapitalreportedUtrecht

Two Sigma VenturesreportedNew York · $2M – $15M

Also in the syndicate · 2

RV InvestSSI Strategy

Reported raises · per SEC filings

Form D private placements

$13.1M disclosed across 3 rounds · 2021–2024

▶$5MraisedNov 2025 · 12 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Katherine PowerDirector
Michael EinzigerExecutive Officer, Director
Edna CoryellExecutive Officer, Director
Ann Marie SimpsonDirector

Offering amount: $5M
Amount sold: $5M
First sale: Apr 2024
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.2MraisedFeb 2023 · 26 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Jessica GoldinExecutive Officer, Director
Ann Marie SimpsonDirector
Michael EinzigerExecutive Officer, Director

Offering amount: $6.2M
Amount sold: $6.2M
First sale: Dec 2022
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedNov 2022 · 16 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Michael EinzigerExecutive Officer, Director
Ann Marie SimpsonDirector
Jessica GoldinExecutive Officer, Director

Offering amount: $2M
Amount sold: $2M
First sale: Jun 2021
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseasesprnewswire.com · Jan 2025

Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules - Hexagonhexagonbio.com · Feb 2023

Frequently asked questions

Who are Small Molecules's investors?: Small Molecules's investors include 8VC, Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, RTW Investments L.P., The Column Group, Thuja Capital, Two Sigma Ventures.
How much funding has Small Molecules raised?: Small Molecules has disclosed $13.1M raised across 3 rounds.
Where is Small Molecules headquartered?: Small Molecules is headquartered in Santa Monica, US.